55331-64-1

Basic information

• Product Name: cyclohexyl 2,3,4-tri-O-acetyl-β-D-glucopyranosiduronic acid methyl ester
• Synonyms: cyclohexyl 2,3,4-tri-O-acetyl-β-D-glucopyranosiduronic acid methyl ester
• CAS NO: 55331-64-1
• Molecular Weight: 416.425
• Mol File: 55331-64-1.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: cyclohexyl 2,3,4-tri-O-acetyl-β-D-glucopyranosiduronic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: cyclohexyl 2,3,4-tri-O-acetyl-β-D-glucopyranosiduronic acid methyl ester(55331-64-1)
• EPA Substance Registry System: cyclohexyl 2,3,4-tri-O-acetyl-β-D-glucopyranosiduronic acid methyl ester(55331-64-1)

Safety Data

• Hazardous Substances Data: 55331-64-1(Hazardous Substances Data)

Upstream product

• 6919-98-8 2,3,4-tri-O-acetyl-1-bromo-1-deoxy-β-D-glucopyranuronic acid methy ester 
• 108-93-0 cyclohexanol 
• 92420-89-8 methyl 2,3,4-tri-O-acetyl-1-O-(trichloroacetimidoyl)-α-D-glucopyranuronate 
• 21085-72-3 1-bromo-2,3,4-tri-O-acetyl-α-D-glucuronic acid methyl ester 
• 186581-53-3 diazomethane 
• 929879-91-4 cyclohexyl 2,3,4-tri-O-acetyl-β-D-glucopyranosiduronic acid 

Downstream Products

• 439905-48-3 O¹-cyclohexyl-β-D-glucopyranuronic acid methyl ester 
• 5285-00-7 O¹-cyclohexyl-β-D-glucopyranuronic acid 

Relevant articles and documents

Glycosidation-anomerisation reactions of 6,1-anhydroglucopyranuronic acid and anomerisation of β-D-glucopyranosiduronic acids promoted by SnCl 4

The reaction of silylated nucleophiles with 6,1-anhydroglucopyranuronic acid (glucuronic acid 6,1-lactones) catalysed by tin(IV) chloride provides 1,2-trans or 1,2-cis (deoxy)glycosides in a manner dependent on the donor structure. The α-glycoside was obt

Glucuronide and sulfate conjugates of ICI 182,780, a pure anti- estrogenic steroid. Order of addition, catalysis and substitution effects in glucuronidation

The 3-sulfate 4 and 3- and 17-glucuronide conjugates 5 and 6 of the pure anti-estrogenic steroid ICI 182,780 1, which is expected to be an effective agent for the treatment of breast cancer, have been prepared. The synthesis of 6 could only be satisfactorily achieved using an inverse addition technique, not previously employed in the glucuronic acid series: the value of this technique for some other aglycones is discussed.